tiprankstipranks

Kevin Tang Insider Profile

25 Followers
Kevin Tang, Director at Heron Therapeutics, holds 372.00K shares in Singular Genomics Systems (Ticker: OMIC), holds 3.85M shares in Rain Oncology (Ticker: RAIN), holds 4.39M shares in TCR2 Therapeutics (Ticker: TCRR). Most recently, Kevin Tang Bought ― shares of Singular Genomics Systems on Sep 18, 2024 for an estimated value of 1.81M.
tipranks
Kevin Tang

Kevin Tang
Heron Therapeutics (HRTX)
Director

Ranked #269 out of 99,335 Corporate Insiders

Profitable Transactions

59%
41 out of 69 Profitable Transactions

Average Return

+27.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$249B
99.99%
<0.01%
<0.01%
<0.01%
<0.01% Others
A breakdown of Kevin Tang's holdings

Insider Roles

Odonate
(ODTC)
CEO, Director, Ten Percent Owner
Vanda
(VNDA)
Ten Percent Owner
Singular Genomics Systems
(OMIC)
Ten Percent Owner
Heron Therapeutics
(HRTX)
Director
+4 other positions
Roles that Kevin Tang holds in companies

Most Profitable Insider Trade

Stock:
La Jolla Pharma
(LJPC)
Rating:Informative Buy
Date:Sep 26, 2014 - Sep 26, 2015
Return:+228.40%
The most profitable trade made by Kevin Tang

Kevin Tang's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Heron Therapeutics
Oct 07, 2019
Director
Informative Buy
5.00M
$6.23M
Cyclacel Pharmaceuticals
Feb 27, 2017
Ten Percent Owner
Informative Buy
581.09K
$199.32K
Odonate
Nov 19, 2021
CEO, Director, Ten Percent Owner
Informative Sell
5.72M
$249.28B
Aptevo Therapeutics
Nov 26, 2021
Exit Filing
Informative Sell
10.36M
$0.00
JNCE
Jounce Therapeutics
May 05, 2023
Uninformative Sell
9.81M
$18.80K
TCRR
TCR2 Therapeutics
May 30, 2023
Informative Buy
86.00K
$6.50M
RAIN
Rain Oncology
Dec 18, 2023
Informative Sell
209.41K
$4.66M
Singular Genomics Systems
Sep 18, 2024
Ten Percent Owner
Informative Buy
1.81M
$7.97M
LJPC
La Jolla Pharma
Dec 01, 2021
Informative Sell
1.73M
$59.76M
Assertio Therapeutics
Ten Percent Owner
$3.59M
ARDMQ
Aradigm
$273.56K
Vanda
Jan 19, 2010
Ten Percent Owner
Informative Sell
589.08K
$13.82M
Molecular Templates
Ten Percent Owner
$956.46K
QCOR
Questcor
GEVA
Synageva
List of latest transactions for each holding click on a transaction to see Kevin Tang's performance on stock

Kevin Tang insider profile FAQ

What is the percentage of profitable transactions made by Kevin Tang?
The percentage of profitable transactions made by Kevin Tang is 59%.
    What is the average return per transaction made by Kevin Tang?
    The average return per transaction made by Kevin Tang is 27.10%.
      What stocks does Kevin Tang hold?
      Kevin Tang holds: HRTX, CYCC, ODTC, APVO, JNCE, TCRR, RAIN, OMIC, LJPC, ASRT, ARDMQ, VNDA, MTEM, QCOR, GEVA stocks.
        What was Kevin Tang’s latest transaction?
        Kevin Tang latest transaction was an Informative Buy of $1.81M.
          What was Kevin Tang's most profitable transaction?
          Kevin Tang’s most profitable transaction was an Informative Buy of LJPC stock on September 26, 2014. The return on the trade was 228.40%.
            What is Kevin Tang's role in Heron Therapeutics?
            Kevin Tang's role in Heron Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.